Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: A systematic review and meta-analysis

Journal of the American Geriatrics Society

Volumn 58, Issue 7, 2010, Pages 1353-1369

  Papaleontiou, Maria ^a   Henderson Jr , Charles R ^b   Turner, Barbara J ^c   Moore, Alison A ^d   Olkhovskaya, Yelena ^e   Amanfo, Leslie ^e   Reid, M Carrington ^e  

^a SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

older adults; opioid; pain

Indexed keywords

BENZATROPINE; BUPRENORPHINE; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DESIPRAMINE; DEXTROPROPOXYPHENE; DICLOFENAC; FENTANYL; GABAPENTIN; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE SULFATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL; SUPROFEN; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADD ON THERAPY; ANALGESIC ACTIVITY; ANOREXIA; ARTICLE; CHRONIC NONCANCER PAI; CHRONIC NONCANCER PAIN; CLINICAL TRIAL; CONSTIPATION; CONTROLLED DRUG RELEASE; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DROWSINESS; DRUG ABUSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MISUSE; DRUG POTENCY; DRUG SAFETY; DRUG WITHDRAWAL; EPIGASTRIC DISTRESS; EVENING DOSAGE; FATIGUE; HUMAN; META ANALYSIS; MORNING DOSAGE; NAUSEA; NERVOUSNESS; NEUROPATHIC PAIN; OPIATE ADDICTION; OSTEOARTHRITIS PAIN; PAIN; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRURITUS; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; STOMACH DISEASE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; VERTIGO; VOMITING; XEROSTOMIA;

AGE FACTORS; AGED; ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; MIDDLE AGED; PAIN; TREATMENT OUTCOME;

EID: 77954339259     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02920.x     Document Type: Article

References (79)

1. Kalso E, Edwards JE, Moore A et al. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 2004 112 : 372 380.
2. Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007 15 : 957 965.
3. Furlan AD, Sandoval JA, Mailis-Gagnon A et al. Review: Opioids are more effective than placebo but not other analgesics for chronic noncancer pain. Can Med Assoc J 2006 174 : 1589 1594.
4. Eisenberg E, McNichol ED, Carr DM. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. JAMA 2005 293 : 3043 3052.
5. Martell BA, O'Connor PG, Kerns RD et al. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007 146 : 116 127.
6. Elliott AM, Smith BH, Penny KI et al. The epidemiology of chronic pain in the community. Lancet 1999 354 : 1248 1252.
7. Helme RD, Gibson SJ. The epidemiology of pain in elderly people. Clin Geriatr Med 2001 17 : 417 431.
8. Blyth FM, March LM, Brnabic AJM et al. Chronic pain in Australia: A prevalence study. Pain 2001 89 : 127 134.
9. Soldato M, Liperoti R, Landi F et al. Non-malignant daily pain and risk of disability among older adults in home care in Europe. Pain 2007 129 : 304 310.
10. American Geriatrics Society Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002 50 : S205 S224.
11. Bryant LL, Grigsby J, Swenson C et al. Chronic pain increases the risk of decreasing physical performance in older adults: The San Luis Valley Health and Aging Study. J Gerontol A Biol Sci Med Sci 2007 62A : 989 996.
12. Reid MC, Williams CS, Gill TM. Back pain and decline in lower extremity physical function among community-living older persons. J Gerontol A Biol Sci Med Sci 2005 60A : 793 797.
13. Scudds RJ, Robertson JM. Empirical evidence of the association between the presence of musculoskeletal pain and physical disability in community-dwelling senior citizens. Pain 1998 75 : 229 235.
14. Bryant LL, Grigsby J, Swenson C et al. Chronic pain increases the risk of decreasing physical performance in older adults: the San Luis Valley Health and Aging Study. J Gerontol Med Sci 2007 62 : 989 996.
15. Leveille SG, Fried L, Guralnik JM. Disabling symptoms: What do older women report? J Gen Intern Med 2002 17 : 766 773.
16. Bell GM, Schnitzer TJ. Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly. Clin Geriatr Med 2001 17 : 489 502.
17. American Geriatric Society Panel on the Pharmacological Management of Peristent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009 57 : 1331 1346.
18. Auret K, Schug SA. Underutilization of opioids in elderly patients with chronic pain: Approaches to correcting the problem. Drugs Aging 2005 22 : 641 654.
19. Upshur CC, Luckmann RS, Savageau JA. Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med 2006 21 : 652 655.
20. Lin JJ, Alfandre D, Moore C. Physician attitudes toward opioid prescribing for patients with persistent noncancer pain. Clin J Pain 2007 23 : 799 803.
21. Solomon DH, Avorn J, Wang PH et al. Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum 2006 55 : 35 41.
22. Deshpande A, Furlan A, Mailis-Gagnon A et al. Opioids for chronic low-back pain. Cochrane Database of Systematic Reviews 2007;(3):CD004959.
23. Jadad AR, Moore A, Carroll D et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clin Trials 1996 17 : 1 12.
24. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions. J Epidemiol Commun Health 1998 52 : 377 384.
25. Ferro MA, Speechley KN. Depressive symptoms among mothers of children with epilepsy: A review of prevalence, associated factors, and impact on children. Epilepsia 2009 50 : 2344 2354.
26. Henderson CR Jr. Analysis of covariance in the mixed model: Higher level, nonhomogeneous, and random regressions. Biometrics 1982 38 : 623 640.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986 7 : 177 188.
28. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 : 629 634.
29. Roth SH, Fleischmann RM, Burch FX et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: Placebo-controlled trial and long-term evaluation. Arch Intern Med 2000 160 : 853 860.
30. Malonne H, Coffiner M, Sonet B et al. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: A multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2004 26 : 1774 1782.
31. Peloso PM, Bellamy N, Bensen W et al. Double blind randomized placebo control trial of controlled-release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000 27 : 764 771.
32. Caldwell JR, Rapoport RJ, Davis JC et al. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: Results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J Pain Symptom Manage 2002 23 : 278 291.
33. Markenson JA, Croft J, Zhang PG et al. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 2005 21 : 524 535.
34. Loet XL, Pavelka K, Richarz U. Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: An open, multicentre study. BMC Musculoskelet Dis 2005 6 : 31.
35. Kjaersgaard-Andersen P, Nafei A, Skov O et al. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomized, double-blind, multi-centre study. Pain 1990 43 : 309 318.
36. Zautra AJ, Smith BW. Impact of controlled-release oxycodone on efficacy beliefs and coping Efforts among osteoarthritis patients with moderate to severe pain. Clin J Pain 2005 21 : 471 477.
37. Choquette D, McCarthy TG, Rodrigues JF et al. Transdermal fentanyl improves pain control and functionality in patients with osteoarthritis: An open-label Canadian trial. Clin Rheumatol 2008 27 : 587 595.
38. Langford R, McKenna F, Ratcliffe S et al. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: A randomized, placebo-controlled trial. Arthritis Rheum 2006 54 : 1829 1837.
39. Hale M, Tudor IC, Khanna S et al. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis. Clin Ther 2007 29 : 874 888.
40. Kivitz A, Ma C, Ahdieh H et al. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 2006 28 : 352 364.
41. Matsumoto AK, Babul N, Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: Results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Med 2005 6 : 357 366.
42. Beaulieu AD, Peloso PM, Haraoui B et al. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: A randomized controlled trial. Pain Res Manage 2008 13 : 103 110.
43. Fleischmann RM, Caldwell JR, Roth SH et al. Tramadol for the treatment of joint pain associated with osteoarthritis: A randomized, double-blind, placebo-controlled trial. Curr Ther Res 2001 62 : 113 127.
44. Schnitzer TJ, Kamin M, Olson WH. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: A randomized, double-blind, placebo-controlled study. Arthritis Rheum 1999 42 : 1370 1377.
45. Babul N, Noveck R, Chipman H et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: A randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004 28 : 59 71.
46. Karlsson M, Berggren AC. Efficacy and safety of low-dose transdermal buprenorphine patches (5,10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Clin Ther 2009 31 : 503 513.
47. Vorsanger G, Xiang J, Jordan D et al. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Clin Ther 2007 29 : 2520 2535.
48. Burch F, Fishman R, Messina N et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage 2007 34 : 328 338.
49. Mongin G, Yakusevich V, Kope A et al. Efficacy and safety of a novel once-daily tablet formulation of tramadol. Clin Drug Invest 2004 24 : 545 558.
50. Emkey R, Rosenthal N, Wu SC et al. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: A multicenter, randomized, double-blind, placebo-controlled trial. J Rheumatol 2004 31 : 150 156.
51. Choi CB, Song JS, Kang YM et al. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain. Clin Ther 2007 29 : 1381 1389.
52. Silverfield JC, Kamin M, Wu SC et al. Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: A multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clin Ther 2002 24 : 282 296.
53. Rosenthal NR, Silverfield JC, Wu SC et al. Tramadol/acetaminophen combination tablets for the treatment of pain associated with osteoarthritis flare in an elderly patient population. J Am Geriatr Soc 2004 52 : 374 380.
54. Roth SH. Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998 25 : 1358 1363.
55. Salzman RT, Brobyn RD. Long-term comparison of suprofen and propoxyphene in patients with osteoarthritis. Pharmacology 1983 27 (Suppl 1) : 55 64.
56. Sasaki J, Weil AJ, Ross EL et al. Effectiveness of polymer-coated extended-release morphine sulfate capsules in older patients with persistent moderate-to-severe pain: A subgroup analysis of a large, open-label, community-based trial. Cur Ther Res 2007 68 : 137 150.
57. Berliner MN, Giesecke T, Bornhovd KD. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis. Clin J Pain 2007 23 : 530 534.
58. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998 41 : 1603 1612.
59. Ringe JD, Faber H, Bock O et al. Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int 2002 22 : 199 203.
60. Peniston JH, Gould E. Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Clin Ther 2009 31 : 347 358.
61. Watson CP, Moulin D, Watt-Watson J et al. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003 105 : 71 78.
62. Hanna M, O'Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008 12 : 804 813.
63. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain. A randomized trial in post-herpetic neuralgia. Neurology 1998 50 : 1837 1841.
64. Raja SN, Haythornthwaite JA, Pappagallo M et al. Opioids versus antidepressants in post-herpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002 59 : 1015 1021.
65. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain 2003 104 : 323 331.
66. Franco ML, Seoane A. Usefulness of transdermal fentanyl in the management of nonmalignant chronic pain: A prospective, observational, multicenter study. Pain Clinic 2002 14 : 99 112.
67. Gatti A, Sabato AF, Carucci A et al. Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain: A prospective observational study. Clin Drug Investig 2009 29 (Suppl 1) : 31 40.
68. Mariconti P, Collini R. Tramadol SR in arthrosic and neuropathic pain. Minerva Anesthesiol 2008 74 : 63 68.
69. Edlund MJ, Steffick D, Hudson T et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007 129 : 355 362.
70. Ives TJ, Chelminski PR, Hammett-Stabler CA et al. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006 6 : 46.
71. Reid MC, Engles-Horton LL, Weber MB et al. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002 17 : 173 179.
72. Dworkin RH, O'Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007 132 : 237 251.
73. Dillie KS, Fleming MF, Mundt MP et al. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med 2008 21 : 108 117.
74. Kalso E, Allan L, Dellemijn PL et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003 7 : 381 386.
75. Won AB, Lapane KL, Vallow S et al. Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr Soc 2004 52 : 867 874.
76. Reid MC, Papaleontiou M, Olkhovskaya Y et al. Should we be prescribing opioids for chronic pain in our older patients? J Am Geriatr Soc 2008 (Suppl) : S175.
77. Nwokeji ED, Rascati KL, Brown CM et al. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with nonmalignant pain. Clin Ther 2007 29 (Suppl) : 589 602.
78. Barry LC, Gill T, Kerns RD et al. Effective pain reduction strategies among community living older persons with chronic pain. J Gerontol A Biol Sci Med Sci 2005 60A : 1569 1575.
79. Anonymous. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997 13 : 6 8.